NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-166-2007-0-US-05 Filipil Compositions And Methods For Treating Cancer US National Stage 12/745,279 8501912 Issued PDF
NICHD E-020-1999-0-US-05 Method of Immunizing Humans Against Salmonella Typhi Using a Vi-rEPA Conjugate Vaccine US DIV 12/790,258 8202520 Expired PDF
NIAID E-078-2009-0-PCT-02 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses (TBEV/DEN4) PCT PCT PCT/US2010/036678 Expired
NINDS E-214-2007-0-US-10 An Implanted System For Sensing, Triggering And Automatically Controlling Swallowing To Maintain Control Of Secretions US CON 12/789,659 Abandoned
NCI E-192-2010-0-US-01 The Development Of NSAID HNO Donor For Cancer And Heart Disease US 61/349,716 Abandoned
NCI E-157-2009-0-PCT-02 MDR1-Inverse Agents PCT PCT PCT/US2010/036348 Expired
NCI E-178-2009-0-PCT-02 Anti-TNF Induced Apoptosis (ATIA) Diagnostic Markers And Therapies PCT PCT PCT/US2010/36394 Expired
NIDCR E-042-2007-0-US-03 Bone Scaffolds, Injectable Bone Repair Materials And Methods For Bone Repair US National Stage 12/745,231 Abandoned
NCI E-196-2000-0-US-04 Defensin-Antigen Fusion Proteins US DIV 12/786,334 7915040 Abandoned PDF
NIAID E-050-1997-1-US-15 Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid US CON 12/785,989 Abandoned
NCI E-191-2009-0-GB-13 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy GB EP 10722881.9 Abandoned
NCI E-191-2009-0-CH-10 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy CH EP 10722881.9 Abandoned
NCI E-191-2009-0-DE-11 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy DE EP 10722881.9 Abandoned
NCI E-191-2009-0-FR-12 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy FR EP 10722881.9 Abandoned
NCI E-191-2009-0-EP-05 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy EP National Stage 10722881.9 Issued
NCI E-191-2009-0-AU-03 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy AU National Stage 2010249401 Abandoned
NCI E-191-2009-0-US-07 AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY US National Stage 13/322,140 8546091 Issued PDF
NCI E-191-2009-0-PCT-02 AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY PCT PCT PCT/US2010/035816 Expired
NIA E-134-2009-0-PCT-02 Engineered Biological Pacemakers PCT PCT PCT/US2010/035823 Expired
NCI E-191-2009-0-CA-04 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy CA National Stage 2762983 Abandoned
NCI E-191-2009-0-JP-06 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy JP National Stage 2012-512066 Pending
NCI E-103-2010-0-US-01 Bispecific Antibody Soluble Receptor Fc Fusion Proteins With Potent And Broad HIV-1 Neutralizing Activity US 61/347,088 Abandoned
NIDA E-221-2010-0-US-01 Phenylmorpholines And Analogues Thereof US 61/347,259 Abandoned
NCI E-130-2010-0-US-01 Synthetic Novel Analogs Of RGD And NGR Cyclic Peptides: Methods of Making, And Methods of Use Thereof US 61/347,038 Abandoned
NIAID E-300-2009-3-US-01 Neutralizing Antibodies to HIV-1 and their Use US 61/346,808 Abandoned
NCI E-086-2001-1-US-05 Peptides Of A Melanoma Antigen And Their Use In Diagnostic, Prophylactic And Therapeutic Methods US DIV 12/782,858 8252545 Expired PDF
NCATS E-134-2010-0-US-01 Inhibitors of Human 12-Lipoxygenase US 61/345,708 Abandoned
NCI E-181-2009-2-PCT-01 Development Of Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain PCT PCT COMB PCT/US2010/035069 Expired
CC E-228-2009-0-EP-05 System And Method Of Integrated Biopsy And Therapy EP National Stage 10727139.7 Issued
CC E-228-2009-0-IN-06 System And Method Of Integrated Biopsy And Therapy IN National Stage 9715/CHENP/2011 Issued
CC E-015-2012-0-EP-04 Tumor Abalation Training System EP National Stage 10727140.5 Issued
CC E-015-2012-0-CN-05 Tumor Abalation Training System CN National Stage 201080029017 Issued
CC E-015-2012-0-JP-06 Tumor Abalation Training System JP National Stage 2012-516884 Issued
CC E-228-2009-0-RU-08 System And Method Of Integrated Biopsy And Therapy RU National Stage 20111054203 Issued
CC E-228-2009-0-CN-04 System And Method Of Integrated Biopsy And Therapy CN National Stage 201080030085.8 Issued
CC E-228-2009-0-JP-07 System And Method Of Integrated Biopsy And Therapy JP National Stage 2012-0513693 Issued
CC E-015-2012-0-PCT-02 Tumor Abalation Training System PCT PCT PCT/IB2010/052153 Expired
CC E-228-2009-0-PCT-02 System And Method Of Integrated Biopsy And Therapy PCT PCT PCT/IB2010/052152 Expired
CC E-228-2009-0-BR-03 System And Method Of Integrated Biopsy And Therapy BR National Stage PI1009004-5 Abandoned
NCI E-163-2009-0-PCT-02 B-cell Surface Reactive Antibodies(B-CLL) PCT PCT PCT/US2010/034491 Expired
NCI E-286-2009-0-US-01 Specimen F2PE (Specimen Fit-For-Purpose Evaluator) US 61/333,900 Abandoned
NCI E-176-2010-0-US-01 Soluble Glypican-3 Inhibits Cancer Growth US 61/334,135 Abandoned
NIAMS E-128-2010-0-US-01 TNFalpha-mediated Cleavage And Inactivation Of SIRT1 In Human Chondrocytes May Indicate Early Signs Of Osteoarthritis US 61/333,479 Abandoned
NCI E-167-2010-0-US-01 Peptide Inhibitors Of Interferon Gamma And Interleukin 10 Signaling US 61/333,512 Abandoned
NIDDK E-129-2010-0-US-01 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNAfor The Multivalent Display Of Ligands` US 61/333,442 Abandoned
NCI E-033-2008-0-US-06 Therapeutic Applications Of A P53 Isoform In Regenerative Medicine, Aging And Cancer US National Stage 12/742,250 8575121 Issued PDF
NCI E-197-2009-0-PCT-02 Soluble TREM-1 Family Peptides And Methods of Use PCT PCT PCT/US10/34263 Abandoned
NIEHS E-156-2009-0-PCT-02 Anti-dsDNA IgM Antibodies To Inhibit Or Reduce The Severity Of Lupus Nephritis Using Anti-dsDNA Germline Antibodies PCT PCT PCT/US10/34257 Expired
NCI E-316-2007-0-US-03 Method of Inhibiting ABCG2 And Related Treatments US National Stage 12/742,039 9114102 Abandoned PDF
NCI E-012-2008-0-US-03 C4-Substitutes-2-Deoxyadenosine Analogs And Methods Of Treating HIV US National Stage 12/741,873 8513214 Abandoned PDF